期刊文献+

应用^(31)P磁共振波谱对心肌梗死后能量代谢变化的评价 被引量:3

Evaluated change of energetic metabolism after myocardial infarction by ^( 31)
下载PDF
导出
摘要 目的 探讨3 1磷磁共振波谱 (3 1PMRS)在心肌梗死临床应用价值 ,评价心肌活力 ,为心肌梗死治疗方案决策提供依据。方法 健康志愿者 12例行3 1PMRS和共振成像 (MRI)检查 ,结果作为正常对照组。选择 10例心肌梗死病人 ,进行MRI和3 1PMRS检查 ,所有病人经冠脉造影等检查证实。结果 与正常对照组比较 ,患者存活心肌PCr/ATP比值无显著差异 ;病变区无活力心肌r-ATP -SNR(thesignaltonoiseratio)与对照组和存活心肌比较明显降低。结论 ①3 1PMRS可以提供存活心肌和梗死 (无活力 )心肌能量代谢变化特征 ,为3 1PMRS评价心肌活力的临床应用提供方法论。②顿抑心肌状态 ,高能磷酸盐代谢变化不是心肌顿抑心功能异常的直接病因。③3 1PMRS显示人心肌梗死能量代谢的变化 ,用3 1PMRS可以预测血管重建后心功能恢复情况。 Objective To study the value of 31 [HT5' P MRS as a passable tool to distinguish viable from non-viable tissue after myocardial infarction in human.Methods Performing MRI and 31 P MRS on 12 healthy volunteers who served as controls.Conducting heart MRI and 31 P MRS studies on 10 selected patients with MI,whose diagnosis of MI has been confirmed by coronary angiographies and some other tests.Results Healthy volunteers served as control group,in viable myocardium,PCr/r-ATP ratio was non-significant vs volunteers;a significant reduction of r-ATP signal-to-noise ratio(SNR) was observed (patients vs volunteers,P<0.05).Conclusions Z ① 31P MRS can provide metabolic characterization of infarcted and viable myocardium.The ability of 31 P MRS examination after reperfusion dramatically increases the likehood that 31 P MRS will have clinical utility for assessing postreperfusion myocardial viability.②The abnormalities of energy phosphate level noted in reperfused-viable (stunned) myocardium are not direct reason for the pathogenesis of mechanical stunning.③ 31P MRS can demonstrate altered energy metabolism in infarcted myocardium in humen.A prediction of functional recovery after revascularization may be possible using 31 P MRS.
出处 《中国急救医学》 CAS CSCD 北大核心 2002年第11期636-638,共3页 Chinese Journal of Critical Care Medicine
关键词 ^31P 磁共振波谱 心肌梗死 能量代谢 评价 Magnetic resonance spectroscopy Phosphorus-31 Myocardial infarction Myocardial metabolism Myocardial ischemia
  • 相关文献

参考文献18

  • 1Hoffmeister HM,Mauser M,Schaper W.Effect of adenosine and AICAR on ATP content and regional contractile function in reperfused canine myocardium[J].Basic Res Cardiol,1992,80(5):445-458.
  • 2Sandstede J,Beer M,Bertsch G, et al.Detection of myocardial viability using dobutamine stress MRI[J].Magn Reson Imaging, 1999,17:1437-1443.
  • 3Baer FM,Theissen P,Schneider CA, et al.Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization[J].J Am Coll Cardiol, 1998,31:1040-1048.
  • 4Wjjns W,Vatner SF,Camici PG.Hibernating myocardium[J].N Engl J Med, 1998,339:173-181.
  • 5Udelson JD.Steps forward in the assessment of myocardial viability in left ventricular function[J].Circulation,1998,97:833-838.
  • 6Geskin G,Kramer CM,Rogers WJ, et al.Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging[J].Circulation, 1998,98:217-223.
  • 7Ahimtoola S.A perspective on the three large multicenter randomized clinical trials of coronary hypass surgery for table angina[J].Circulation,1985,72(suppl V):V-123-V-135.
  • 8Braunwald E,Kloner RA.The stunned myocardium:prolonged,postischemic ventricular dysfunction[J].Circulation,1982,66:1146-1149.
  • 9Neubauer S,Krahe T,Schindler R, et al.Cardiac 31 P-magnetic resonance spectroscopy of volunteers and patients with coronary artery disease and dilated cardiomyopathy.Altered cardiac high-energy phosphate metabolism in heart failure[J].Circulation, 1992,86:1810-1818.
  • 10Yabe T,Mitsunami K,Inubushi T, et al.Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31 P magnetic resonance spectroscopy[J].Circulation, 1995,92:15-23.

同被引文献18

  • 1胡元会,曹雪滨,曹贵民,黄启福,陆文云,范启霞.心复康口服液对实验心衰模型大鼠心肌细胞自由基代谢和膜通透性的影响[J].中国中医基础医学杂志,2000,6(2):16-19. 被引量:27
  • 2苏晓华,姜晓姝,王孝铭,焦选茂,刘树森.Captopril对缺血再灌心肌线粒体电子质子偶联和氧化磷酸化的影响[J].中国病理生理杂志,1996,12(3):316-319. 被引量:8
  • 3宋涛,李臣文,赵文秀,葛志明.心肌缺血的能量代谢及代谢药物治疗[J].实用心脑肺血管病杂志,2006,14(10):766-768. 被引量:13
  • 4曹雪滨 李培建 黄河玲 等.心复康口服液对大鼠实验性心肌缺血的保护作用.中国药科大学学报,1998,29:196-198.
  • 5曹雪滨 沐贤友 陈德玲 等.心复康口服液治疗充血性心力衰竭的临床研究.临床荟萃,1998,13(14):7980-7980.
  • 6Buser PT. Camacho SA, Wu ST, et al. The effect of dobutamine on myocardia/ performance and high-energy phosphate metabolism at different stages of heart failure in cardiomyopathic hamsters: a 31PNMR study[J]. Am Heart J, 1989,118( 1 ) :86-91.
  • 7Murry CE, Richand V J, Reimer KA, et al. Ischemic preconditioning. Slows energy metabolism and delays ultra structure damage during a sustained ischemic episode[ J]. CirRes, 1990,66:913-918.
  • 8Sivitz WI, Lund DD, Yorek B, et al. Pretranslational regulation of two cardiac glucose transporters in rats exposed to hypobaric hypoxia[J]. Am J Physiol, 1992,263 (32) : 562-569.
  • 9GrynbergA, Demaison L. Fatty acid oxidation in the heart[ J]. Cardiovasc Pharmacol, 1996,28 (Suppl) :11- 17.
  • 10张镜茹.生理学[M].北京:人民卫生出版社,1996:218.

引证文献3

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部